Evidence map›Paper›PMID 40008243›Full record

ArticleParasite epidemiology and control2025

Residual transmission of schistosomiasis in Ndikinimeki Health District (Centre Region, Cameroon) despite implementation of complementary control strategies: Prospects for elimination.

Hervé Kengne Fogang, Hugues C Nana Djeunga, Alvine C Kengne-Fokam, Murielle C Tchami Mbagnia, Flobert Njiokou, Dickson S Nsagha, Emmanuel Yenshu, Joseph Kamgno

Abstract read
In one paragraph

Article in Parasite epidemiology and control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hervé Kengne FogangDepartment of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Hugues C Nana DjeungaHigher Institute for Scientific and Medical Research (ISM), Yaoundé, Cameroon.
Alvine C Kengne-FokamParasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
Murielle C Tchami MbagniaParasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
Flobert NjiokouParasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
Dickson S NsaghaDepartment of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Emmanuel YenshuDepartement of Sociology and Anthropology, Faculty of Social Science and Management, University of Buea, Buea, Cameroon.
Joseph KamgnoHigher Institute for Scientific and Medical Research (ISM), Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis control currently relies on school-based preventive chemotherapy (PC) with praziquantel, which has been proven, unfortunately, insufficient to interrupt disease transmission in areas with persistent transmission. In the Ndikinimeki Health District (Centre Region, Cameroon), complementary strategies (community-based preventive chemotherapy, water sanitation, hygiene, and health education) have also been implemented to accelerate the interruption of schistosomiasis transmission in this focus. The assessment of the impact of this package of interventions revealed that only a few individuals were still infected with

Indexed as

Biomphalaria camerunensisBiomphalaria pfeifferiBulinus forskaliiCameroonMalacological surveyNdikinimeki Health DistrictSchistosoma mansoni

Identifiers

PMID40008243
PMCPMC11852676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.